Your browser doesn't support javascript.
loading
Inhibition of p53-MDM2 binding reduces senescent cell abundance and improves the adaptive responses of skeletal muscle from aged mice.
Nolt, Georgia L; Keeble, Alexander R; Wen, Yuan; Strong, Aubrey C; Thomas, Nicholas T; Valentino, Taylor R; Brightwell, Camille R; Murach, Kevin A; Patrizia, Sini; Weinstabl, Harald; Gollner, Andreas; McCarthy, John J; Fry, Christopher S; Franti, Michael; Filareto, Antonio; Peterson, Charlotte A; Dungan, Cory M.
Afiliação
  • Nolt GL; Department of Physiology, University of Kentucky, Lexington, KY, USA.
  • Keeble AR; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Wen Y; Department of Physiology, University of Kentucky, Lexington, KY, USA.
  • Strong AC; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Thomas NT; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Valentino TR; Department of Physical Therapy, University of Kentucky, Lexington, KY, USA.
  • Brightwell CR; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Murach KA; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Patrizia S; Department of Athletic Training and Clinical Nutrition, University of Kentucky, Lexington, KY, USA.
  • Weinstabl H; Department of Physiology, University of Kentucky, Lexington, KY, USA.
  • Gollner A; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • McCarthy JJ; The Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Fry CS; Department of Athletic Training and Clinical Nutrition, University of Kentucky, Lexington, KY, USA.
  • Franti M; Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, AR, USA.
  • Filareto A; Regenerative Medicine, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Peterson CA; Boehringer Ingelheim RCV, Boehringer Ingelheim Pharmaceuticals Inc., Vienna, Austria.
  • Dungan CM; Boehringer Ingelheim RCV, Boehringer Ingelheim Pharmaceuticals Inc., Vienna, Austria.
Geroscience ; 46(2): 2153-2176, 2024 Apr.
Article em En | MEDLINE | ID: mdl-37872294
Skeletal muscle adaptation to external stimuli, such as regeneration following injury and hypertrophy in response to resistance exercise, are blunted with advanced age. The accumulation of senescent cells, along with defects in myogenic progenitor cell (MPC) proliferation, have been strongly linked as contributing factors to age-associated impairment in muscle adaptation. p53 plays an integral role in all these processes, as upregulation of p53 causes apoptosis in senescent cells and prevents mitotic catastrophe in MPCs from old mice. The goal of this study was to determine if a novel pharmaceutical agent (BI01), which functions by upregulating p53 through inhibition of binding to MDM2, the primary p53 regulatory protein, improves muscle regeneration and hypertrophy in old mice. BI01 effectively reduced the number of senescent cells in vitro but had no effect on MPC survival or proliferation at a comparable dose. Following repeated oral gavage with 2 mg/kg of BI01 (OS) or vehicle (OV), old mice (24 months) underwent unilateral BaCl2 injury in the tibialis anterior (TA) muscle, with PBS injections serving as controls. After 7 days, satellite cell number was higher in the TA of OS compared to OV mice, as was the expression of genes involved in ATP production. By 35 days, old mice treated with BI01 displayed reduced senescent cell burden, enhanced regeneration (higher muscle mass and fiber cross-sectional area) and restoration of muscle function relative to OV mice. To examine the impact of 2 mg/kg BI01 on muscle hypertrophy, the plantaris muscle was subjected to 28 days of mechanical overload (MOV) in OS and OV mice. In response to MOV, OS mice had larger plantaris muscles and muscle fibers than OV mice, particularly type 2b + x fibers, associated with reduced senescent cells. Together our data show that BI01 is an effective senolytic agent that may also augment muscle metabolism to enhance muscle regeneration and hypertrophy in old mice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Músculo Esquelético Limite: Animals Idioma: En Revista: Geroscience Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Músculo Esquelético Limite: Animals Idioma: En Revista: Geroscience Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos